While not yet widely available, it represents the future of GLP-1-based weight loss treatments
Bold marketing claims should be treated with scepticism regardless of the format
publicly announced an intent to reclassify roughly 14 of the 19 Category 2 peptides including BPC-157, TB-500, CJC-1295, and thymosin alpha-1 from Category 2 back toward Category 1, which would permit 503A compounding
Shree S
Kiara DeWitt, BSN, RN, CPN Founder & Advanced Clinical Nurse Injector Botox & Filler Procedures years Injector Experience Kiara founded InjectCo in 2021 with a vision to combine ethics, education, and artistry in aesthetics
Thus, this situation also may affect the results (Reference Steiner, Herring and Kesner46)